Article Information
History
- April 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Steef Kurstjens1,
- Armando van der Horst1,
- Robert Herpers2,
- Mick W.L. Geerits3,
- Yvette C.M. Kluiters-de Hingh4,
- Eva-Leonne Göttgens5,
- Martinus J.T. Blaauw6,
- Marc H.M. Thelen5,7,8,
- Marc G.L.M. Elisen4,9 and
- Ron Kusters1,10,*
- 1Laboratory of Clinical Chemistry and Hematology, Jeroen Bosch Hospital, Den Bosch, the Netherlands
- 2Laboratory of Clinical Chemistry and Hematology, Bernhoven Hospital, Uden, the Netherlands
- 3Abnormal Design Ltd, London, United Kingdom
- 4Laboratory of Clinical Chemistry & Hematology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands
- 5Laboratory of Clinical Chemistry and Hematology, Amphia Hospital, Breda, the Netherlands
- 6Department of Internal Medicine, Bernhoven Hospital, Uden, the Netherlands
- 7Dutch Foundation for Quality Assessment in Medical Laboratories (SKML), Nijmegen, the Netherlands
- 8Chair in ‘quality in medical laboratory care’, Radboud University, Nijmegen, the Netherlands
- 9Netherlands Society of Clinical Chemistry & Laboratory Medicine (NVKC), Utrecht, the Netherlands
- 10Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, the Netherlands
- ↵*Corresponding author: Ron Kusters, PhD, Laboratory for Clinical Chemistry and Hematology, Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands, P.O. Box 90153, 5223 GZ Den Bosch, the Netherlands, E-mail: r.kusters{at}jbz.nl, Telephone: +31621825927
Posted April 24, 2020.
Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing
